New insights into the modulation of immune response by Fasciola hepatica excretory-secretory products

Current Immunology Reviews

Volumn 5, Issue 4, 2009, Pages 277-284

  Cervi, Laura ^a   Serradell, Marianela C ^a   Guasconi, Lorena ^a   Masih, Diana T ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Dendritic cells; Eosinophils; Evasion mechanisms; Fasciola hepatica; Innate immunity; Macrophages

Indexed keywords

NATURAL PRODUCT;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL MATURATION; DENDRITIC CELL; EOSINOPHIL; FASCIOLA HEPATICA; HELMINTHIASIS; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; TARGET CELL; TH2 CELL;

EID: 70350754351     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339509789503961     Document Type: Review

References (76)

1. McManus DP, Dalton JP. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology 2006; 133(Suppl): S43-61.
2. Piedrafita D, Parsons JC, Sandeman RM, et al. Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunol 2001; 23: 473-482
3. Trottein FS, Nutten V, Angeli P, et al. Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway. Eur J Immunol 1999; 29: 3691-3701
4. Shin MH, Kita H, Park HY, Seoh JY. Cysteine protease secreted by Paragonimus wetermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G. Infect Immun 2001; 69: 1599-1604 (Pubitemid 32187615)
5. Semnani RT, Liu AY, Sabzevari HJ, et al. Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J Immunol 2003; 171:1950-1960
6. Anthony RM, Rutitzky LI, Urban JF, Jr. Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007; 7: 975-987
7. Wildblood LA, Kerr K, Clark DA, Cameron A, Turner DG, Jones DG. Production of eosinophil chemoattractant activity by ovine gastrointestinal nematodes. Vet Immunol Immunopathol 2005; 107: 57-65. (Pubitemid 40848505)
8. Turner DG, Wildblood LA, Inglis NF, Jones DG. Characterization of a galectin-like activity from the parasitic nematode, Haemonchus contortus, which modulates ovine eosinophil migration in vitro. Vet Immunol Immunopathol 2008; 122: 138-145
9. Milbourne EA, Howell MJ. Eosinophil differentiation in response to Fasciola hepatica and its excretory/secretory antigens. Int J Parasitol 1993; 23: 1005-1009
10. Sabin EA, Kopf MA, Pearce EJ. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996; 184: 1871-1878
11. David JR, Butterworth AE, Vadas MA. Mechanism of the interaction mediating killing of Schistosoma mansoni by human eosinophils. Am J Trop Med Hyg 1980; 29: 842-848
12. Haque AA, Ouaissi M, Joseph M, Capron A. IgE antibody in eosinophil- and macrophage-mediated in vitro killing of Dipetalonema viteae microfilariae. J Immunol 1981; 127: 716-725
13. Kazura JW, Grove DI. Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis. Nature 1978; 274: 588-589
14. Van Milligen FJ, Cornelissen JB, Hendriks IM, Gaasenbeek CP, Bokhout BA. Protection of Fasciola hepatica in the gut mucosa of immune rats is associated with infiltrates of eosinophils, IgG1 and IgG2a antibodies around the parasites. Parasite Immunol 1998; 20: 285-292
15. Duffus WP, Thorne K, Oliver R. Killing of juvenile Fasciola hepatica by purified bovine eosinophil proteins. Clin Exp Immunol 1980; 40: 336-344 (Pubitemid 10113468)
16. Duffus WP, Franks D. In vitro effect of immune serum and bovine granulocytes on juvenile Fasciola hepatica. Clin Exp Immunol 1980; 41: 430-440
17. Chapman CB, Mitchell GF. Proteolytic cleavage of immunoglobulin by enzymes released by Fasciola hepatica. Vet Parasitol 1982; 11: 165-178
18. Carmona C, Dowd AJ, Smith AM, Dalton JP. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol Biochem Parasitol 1993; 62: 9-17.
19. Piedrafita D, Estuningsih E, Pleasance J, et al. Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica. Infect Immun 2007; 75: 1954-1963
20. Niwa A, Miyazato T. Reactive oxygen intermediates from eosinophils in mice infected with Hymenolepis nana. Parasite Immunol 1996; 18: 285-295 (Pubitemid 26227977)
21. Serradell MC, Guasconi L, Cervi L, Chiapello LS, Masih DT. Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet Immunol Immunopathol 2007; 117: 197-208. (Pubitemid 46711212)
22. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007; 119: 1313-1320
23. Knott ML, Matthaei KI, Giacomin PR, Wang H, Foster PS, Dent LA. Impaired resistance in early secondary Nippostrongylus brasiliensis infections in mice with defective eosinophilopoeisis. Int J Parasitol 2007; 37:1367-1378 (Pubitemid 47285107)
24. Galioto AM, Hess JA, Nolan TJ, Schad GA, Lee JJ, Abraham D. Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice. Infect Immun 2006; 74: 5730-5738 (Pubitemid 44484558)
25. Swartz JM, Dyer KD, Cheever AW, et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 2006; 108: 2420-2427 (Pubitemid 44497528)
26. Reiman RM, Thompson RW, Feng CG, et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 2006; 74: 1471-1479
27. Serradell MC, Guasconi L, Masih DT. Involvement of a mitochondrial pathway and key role of hydrogen peroxide during eosinophil apoptosis induced by excretory-secretory products from Fasciola hepatica. Mol Biochem Parasitol 2009; 163: 95-106.
28. McGonigle S, Curley GP, Dalton JP. Cloning of peroxiredoxin, a novel antioxidant enzyme, from the helminth parasite Fasciola hepatica. Parasitology 1997; 115 ( Pt 1): 101-104 (Pubitemid 27337233)
29. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
30. Reyes JL, Terrazas LI. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol 2007; 29: 609-619
31. Choi BS, Martinez-Falero IC, Corset C, et al. Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages. J Leukoc Biol 2009; 85: 268-277
32. Donnelly S, Stack CM, O'Neill SM, Sayed AA, Williams DL, Dalton JP. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J 2008; 22: 4022-4032
33. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Ann Rev Immunol 2008.
34. Donnelly S, O'Neill SM, Sekiya M, Mulcahy G, Dalton JP. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun 2005; 73: 166-173 (Pubitemid 40041106)
35. Loke P, Gallagher I, Nair MG, et al. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 2007; 179: 3926-3936
36. Herbert DR, Holscher C, Mohrs M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004; 20: 623-635 (Pubitemid 38659504)
37. Goodridge HS, Marshall FA, Else KJ, et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol 2005; 174: 284-293
38. Cervi L, Rossi G, Masih DT. Potential role for excretory-secretory forms of glutathione-S-transferase (GST) in Fasciola hepatica. Parasitology 1999; 119 ( Pt 6): 627-633
39. Flynn RJ, Mulcahy G. Possible role for Toll-like receptors in interaction of Fasciola hepatica excretory/secretory products with bovine macrophages. Infect Immun 2008; 76: 678-684 (Pubitemid 351251739)
40. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 2001; 166: 2173-2177 (Pubitemid 32173445)
41. Smits HH, Yazdanbakhsh M. Chronic helminth infections modulate allergen-specific immune responses: protection against development of allergic disorders? Ann Med 2007; 39: 428-439
42. Prieto-Lafuente L, Gregory WF, Allen JE, Maizels RM. MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages. J Leukoc Biol 2009.
43. Raes G, Brys L, Dahal BK, et al. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukoc Biol 2005; 77: 321-327 (Pubitemid 40289561)
44. Rogers NC, Slack EC, Edwards AD. Reis e Sousa. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 2005; 22: 507-517
45. Dillon S, Agrawal S, Banerjee K, et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 2006; 116: 916-928
46. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969
47. Patel N, Kreider T, Urban JF Jr, Gause WC. Characterisation of effector mechanisms at the host:parasite interface during the immune response to tissue-dwelling intestinal nematode parasites. Int J Parasitol 2009; 39: 13-21.
48. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311:17-58. (Pubitemid 47413194)
49. Sher A, Pearce E, Kaye P. Shaping the immune response to parasites: role of dendritic cells. Curr Opin Immunol 2003; 15: 421-429 (Pubitemid 36930079)
50. Pulendran B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J Immunol 2005; 174: 2457-2465 (Pubitemid 40279654)
51. Reis e Sousa C, Diebold SD, Edwards AD, Rogers N, Schulz O, Sporri R. Regulation of dendritic cell function by microbial stimuli. Pathol Biol 2003; 51: 67-68
52. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 2007; 82:1365-1374 (Pubitemid 350276946)
53. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006; 108:1435-1440 (Pubitemid 44316106)
54. MacDonald AS, Straw AD, Bauman B, Pearce EJ. CD8- dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001; 167:1982-1988 (Pubitemid 32747504)
55. Taylor BC, Zaph C, Troy AE, et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J Exp Med 2009; 206: 655-667
56. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6: 507-514 (Pubitemid 41716764)
57. Kane CM, Cervi L, Sun J, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173: 7454-7461 (Pubitemid 39628185)
58. Balic A, Harcus Y, Holland MJ, Maizels RM. Selective maturation of dendritic cells by Nippostrongylus brasiliensis-secreted proteins drives Th2 immune responses. Eur J Immunol 2004; 34: 3047-3059 (Pubitemid 39549384)
59. Thomas PG, Carter MR, Atochina O, et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol 2003; 171: 5837-5841 (Pubitemid 37467200)
60. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129 (Pubitemid 35470760)
61. van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007; 212: 475-490 (Pubitemid 46825248)
62. Wang CR, Qiu JH, Zhu XQ, et al. Survey of helminths in adult sheep in Heilongjiang Province, People's Republic of China. Vet Parasitol 2006; 140: 378-382 (Pubitemid 44500660)
63. Tliba O, Moire N, Le Vern Y, Boulard C, Chauvin A, Sibille P. Early hepatic immune response in rats infected with Fasciola hepatica. Vet Res 2002; 33: 261-270 (Pubitemid 34578311)
64. Brady MT, O'Neill SM, Dalton JP, Mills KH. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun 1999; 67: 5372-5378
65. Cervi L, Rubinstein H, Masih DT. Involvement of excretion-secretion products from Fasciola hepatica inducing suppression of the cellular immune responses. Vet Parasitol 1996; 61: 97-111. (Pubitemid 26025847)
66. Diaz A, Allen JE. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol 2007; 37: 3319-3326
67. McKee AS, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 1224-1231
68. Yang J, Zhao J, Yang Y, et al. Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma. Immunology 2007; 120: 8-18.
69. Reddy A, Fried B. An update on the use of helminths to treat Crohn's and other autoimmunune diseases. Parasitol Res 2009; 104: 217-221
70. Reddy A, Fried B. The use of Trichuris suis and other helminth therapies to treat Crohn's disease. Parasitol Res 2007; 100: 921-927 (Pubitemid 46354885)
71. Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128: 825-832 (Pubitemid 40523535)
72. Hsu SJ, Tseng PH, Chen PJ. Trichuris suis therapy for ulcerative colitis: nonresponsive patients may need anti-helminth therapy. Gastroenterology 2005; 129: 768-9; author reply 769.
73. Sewell D, Qing Z, Reinke E, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003; 15: 59-69. (Pubitemid 36163769)
74. Coquerelle C, Moser M. Are dendritic cells central to regulatory T cell function? Immunol Lett 2008; 119:12-16
75. Lange C, Durr M, Doster H, Melms A, Bischof F. Dendritic cell-regulatory T-cell interactions control self-directed immunity. Immunol Cell Biol 2007; 85: 575-581 (Pubitemid 350224203)
76. Steinman RM, Hawiger D, Liu K, et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann NY Acad Sci 2003; 987: 15-25.